DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Five-Star Business Finance Limited — Analyst/Investor Meet Para A-XBRL

NSE 30 min ago·29 Jul 2026, 1:19 pm

Strides Pharma SCI

Five-Star Business Finance Limited has informed stock exchanges about an upcoming meeting with analysts and institutional investors. This event is scheduled under the Para A-XBRL category, which is used to disclose information regarding interactions with the investment community.

For investors, such meetings are significant because they provide a platform for the company to communicate its future strategy, financial outlook, and business plans directly to the market. It offers a chance for the management to address queries and clarify the company's direction, which can help in assessing the stock's potential.

Investors should watch for any specific guidance or updates on business performance that the management might share during the interaction. This information can be crucial for making informed decisions about the company's future prospects.